Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Payables (2019 - 2025)

Historic Payables for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $590068.0.

  • Bioadaptives' Payables rose 1670.72% to $590068.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $590068.0, marking a year-over-year increase of 1670.72%. This contributed to the annual value of $490458.0 for FY2024, which is 3590.77% down from last year.
  • Latest data reveals that Bioadaptives reported Payables of $590068.0 as of Q3 2025, which was up 1670.72% from $515081.0 recorded in Q2 2025.
  • Bioadaptives' 5-year Payables high stood at $831413.0 for Q2 2022, and its period low was $448862.0 during Q1 2021.
  • In the last 5 years, Bioadaptives' Payables had a median value of $732830.0 in 2022 and averaged $665323.5.
  • Per our database at Business Quant, Bioadaptives' Payables skyrocketed by 6326.4% in 2022 and then plummeted by 3590.77% in 2024.
  • Over the past 5 years, Bioadaptives' Payables (Quarter) stood at $650867.0 in 2021, then rose by 21.64% to $791713.0 in 2022, then fell by 3.34% to $765237.0 in 2023, then plummeted by 35.91% to $490458.0 in 2024, then rose by 20.31% to $590068.0 in 2025.
  • Its last three reported values are $590068.0 in Q3 2025, $515081.0 for Q2 2025, and $507816.0 during Q1 2025.